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ABSTRACT 
The  dynamics of the  toxin  Ricinus  communis  agglutinin  II (RCAH or ricin)  on 
cells  of a  murine  lymphoma  line  (BW5147)  and  a  toxin-resistant  variant  line 
(BW5147Ric R. 3) that is 200 times more resistant than the parent to direct RCA  n 
cytotoxicity were examined using ferritin-conjugated, affinity purified, lzsI-labeled 
RCAII (ferritin-125I-RCAn). Ferritin-125I-RCAn was indistinguishable from native 
RCA~  I in  quantitative  binding  and cytotoxicity experiments.  When  RCAt~-sensi- 
tive BW5147  and -resistant BW5147Ric R. 3  cells were labeled with ferritin-125I  - 
RCAH  at  various  toxin  concentrations  (1-10  /xg/ml),  no  differences  in  toxin 
binding were observed. These same cells were examined by electron microscopy. 
At  low  ferritinJZSI-RCAH  concentrations  (1-3  /,~g/ml  RCAn)  where  only  the 
parental BW5147 cells were significantly more sensitive to RCAI~, toxin receptors 
were  internalized  by ferritin-125I-RCAii-induced  endocytosis.  In parallel  experi- 
ments,  ferritinJ25I-RCAH  that  bound  to  the  resistant  BW5147Rica. 3  cells 
remained  relatively  dispersed  or  clustered,  and  there  was  little  evidence  of 
transport  into cells via endocytosis.  At  higher ferritin-~25I-RCAH concentrations 
(>7/zg/ml RCAI0 where both parental and resistant variant cells are sensitive to 
the  cytotoxic effects of RCAH,  more  ferritin-conjugated  toxin  was bound,  and 
subsequent  endocytosis occurred to a  similar degree in  both cell types. Endocy- 
tosis  of  ferritin-conjugated  concanavalin  A  was  indistinguishable  on  RCAIr 
sensitive  parental  and  resistant  variant  cells  at  all  concentrations  tested.  The 
results suggest that a specific defect on the selected BW5147Ric a. 3 cells prevents 
RCAn  entry  into  these  cells  at  low toxin  concentrations,  rendering  them  more 
resistant to the cytotoxic effects of RCAH. 
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Certain  proteins and glycoproteins isolated from 
plants are extremely toxic to animals and man (2, 
19,  37). An  -60,000 mol wt glycoprotein (Rici- 
nus communis  agglutinin  II [RCAH or ricin]) 1 that 
1 Abbreviations  used in this paper:  BSA, bovine serum 
albumin; Con  A, concanavalin A;  DMEM, Dulbecco 
modified  minimal essential medium; DMEM-BSA, 
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plant  (Ricinus  cornmunis)  (11,  24,  25,  35,  38, 
49)  inhibits  proteirr synthesis  in  intact  cells (12- 
14,  27,  38)  and  in  cell-free  protein  synthesis 
systems  (17,  27,  32-34,  43).  The  toxicity  of 
RCAtt or ricin has been utilized in experiments to 
differentially kill tumor cells in vitro (27)  as well 
as in animals (12, 41) and man (8, 50). 
The cellular toxicity of RCAu (ricin) is generally 
thought  to  occur  via  the  following  sequence  of 
events:  Toxin  molecules  bind  to  the  cell surface 
and induce redistribution of their receptors. Some 
of  the  aggregated  toxin-receptor  complexes  are 
endocytosed into the cell where  after a  period of 
time a proportion of the endocytotic vesicles break 
down,  releasing toxin  molecules into  the cell cy- 
toplasm where they irreversibly inactivate protein 
synthesis  (18,  27,  32,  38,  40,  43,  45).  To study 
this sequence  in more detail, several somatic cell 
mutants have been isolated that are more resistant 
to the direct toxic effects of RCA~ or other lectins 
(7, 9, 16, 17, 44, 46-48). Although many of these 
toxin-  and  lectin-resistant  mutants  possess  cell 
surface changes leading to large decreases in toxin 
or  lectin  binding  (6,  7,  17),  certain  resistant 
variants are capable of binding substantial  quanti- 
ties  of  toxin  or  lectin  molecules  to  their  cell 
surfaces  (9,  16,  44).  One  such  variant  cell  line 
which was selected from a  murine lymphoma cell 
line  by  direct  RCAa  cytotoxicity  is  -200  times 
more resistant compared to its parental line in the 
absence  of serum,  although it has lost only -30- 
40%  of its total cell-binding sites for RCAa (44). 
Cell-free protein synthesis studies suggest that the 
ribosomes of the  RCA~rresistant  variant  line are 
just  as  sensitive to  toxin  inactivation  as  parental 
ribosomes, indicating that the properties of resist- 
ance must reside at a site(s) other than the level of 
protein synthesis (43).  In addition, although most 
surface  proteins on  the  resistant  variant cells are 
similar to parental cell surface  proteins as judged 
by electrophoresis after lactoperoxidase-catalyzed 
iodination  or  affinity  chromatography  of  mem- 
brane  glycoproteins,  a  surface  glycoprotein  of 
~80,000  mol wt on the surfaces of parental  cells 
DMEM plus 0.1% bovine serum albumin; ferritin-Con 
A,  ferritin-conjugated  concanavalin  A;  ferritin-~25I  - 
RCAn, ferritin-conjugated, lzSI-labeled RCAH; PBS 1, 
0.2  M  sodium  chloride-0.005  M  sodium  phosphate 
buffer,  pH  7.2;  PBS  2,  1 M  sodium chloride-0.05  M 
sodium phosphate buffer, pH 6.8; RCAtI, Ricinus com- 
munis agglutinin  II. 
is altered on the variant cells to a  lower apparent 
molecular weight component  (44).  In preliminary 
nonquantitative experiments, it appeared  that the 
resistant variant cells might not transport  ferritin- 
RCAH at  the  same  rate  as  the  parental  sensitive 
cells (28).  We now report  in  detail,  using a  fully 
biologically  active,  quantitative,  electron-dense 
probe  consisting  of  ferritin-conjugated,  r'SI-la- 
beled-RCAH (ferritin-12SI-RCAn), that  the RCAII 
toxin  molecules  bind  to  cell  surfaces  of  both 
resistant  and  sensitive  cells.  However,  at  low 
RCAII concentrations where the maximum differ- 
ential toxic effects occur, the ricin molecules only 
enter at significant levels into the sensitive cells. 
MATERIALS  AND  METHODS 
Biochemicals and Chemicals 
Bovine serum albumin (BSA, three times crystallized) 
was  obtained from Armour Pharmaceuticals  (Chicago, 
Ill.). Ferritin was  purchased  from Immuno-Diagnostics 
(Solana  Beach,  Calif.)  and  NamI  (~17  Ci/mg) from 
International  Nuclear Corp. (Irvine, Calif.).  L-[SH]leucine 
(30 Ci/mmol) was  bought  from New England  Nuclear 
(Boston, Mass.), and osmium tetroxide and glutaralde- 
hyde,  EM  grade,  were  obtained  in  sealed  vials  from 
Polysciences,  Inc., (Warrington, Pa.). Saccharides  were 
products  of  Calbiochem  (San  Diego,  Calif.),  and  all 
inorganics  were obtained  from  Mallinckrodt,  Inc.  (St. 
Louis, Mo.). 
Cell Lines and Growth 
The BW5147 cell line is a spontaneous AKR/J lym- 
phoma that has been adapted to tissue culture and grows 
in suspensions  with Dulbecco modified minimal essential 
medium (DMEM) plus 2 mM glutamine and 10% horse 
serum. A thioguanine-resistant subelone (BW5147. G. 1  ) 
is defined here as the parental  BW5147  cell line (10) 
from  which  an  RCA,rresistant  variant  line 
(BW5147RicR.3)  was  obtained  by  stepwise  selection 
over  1  yr  against  a  series  of  RCA n  concentrations 
increasing  from  5  x  10 _3  p,g/ml  to  1  ~,g/ml.  The 
BW5147RicR.3  variant  cell  line  is  -200  times  more 
resistant  compared  to  the  parental  BW5147  line,  as 
measured by the ability of the cells to survive  a 60-min 
exposure to RCAI~ in serum-free medium. These exper- 
iments were repeated with ferritin-RCAn conjugates as 
follows:  UV-sterilized toxin  or ferritin-toxin conjugate 
was  diluted  in  DMEM  plus  0.1%  crystalline  bovine 
serum albumin (DMEM-BSA) in place of DMEM plus 
horse  serum.  The cells  were washed  once in  DMEM- 
BSA, counted, and suspended in  DMEM-BSA to 2  ￿ 
10  ~ cells/ml.  Ferritin-mI-RCAii or  RCAII  (1  ml) and 
cells (1 ml) were mixed on ice and then transferred to a 
humidified tissue culture incubator at 37~  After a 60- 
min incubation  with agitation every  15  min, the tubes 
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horse serum was added, and the ceils were washed twice 
by centrifugation (600  g  for 5  min  at  4~  The cells 
were then  resuspended in  2  ml  of DMEM containing 
10%  horse serum  and  inoculated into  35-mm  dishes. 
The dishes were sampled initially and at 48 and 72 h to 
determine the number of live/dead cells by trypan blue 
dye exclusion. 
Cell  protein  synthesis was  measured  as  described 
previously  (27),  using log phase cells.  Cultures treated 
with an inhibitory concentration of RCAn or ferritin-~2sI  - 
RCA  a for various times in DMEM-BSA were washed in 
DMEM  minus  L-leucine  plus  5%  horse  serum  and 
incubated  in  the  same  medium  at  37~  in  a  COs 
incubator for 60 or 120 rain with added [aH]leucine  (3 
~Ci/ml).  After the  incubation, the  cells  were washed 
three times with phosphate-buffered  saline and dissolved 
in  1 ml of NaOH  containing 0.1%  BSA.  Protein was 
precipitated by addition of 4-5 vol of cold 10% TCA, 
and after a  60-min  incubation at  4~  the precipitates 
were filtered through Whatman GF/C glass filters. Fil- 
ters were washed twice with 5% TCA, once with 95% 
ethanol, dried, and aH was determined in a scintillation 
counter. 
Lectins and Ferritin-  ~251- 
Lectin  Conjugates 
Concanavalin A  (Con A) obtained from Calbiochem 
was  affinity  purified  according  to  the  procedures  of 
Agrawal and Goldstein (1). RCA. was affinity purified 
from Ricinus communis extracts by the method of Nicol- 
son and Blaustein  (24). RCA  n was labeled with lZSl by 
the McFarlane (15) procedures as described previously 
(25).  Ferritin conjugates were synthesized and purified 
by  a  modification of the  procedures of Nicolson  and 
Singer (29).  I~SI-RCAn was  added to  purified ferritin 
(Immuno-Diagnostics) in a ratio of 1:5 wt/wt in 0.2 M 
sodium chloride-0.005 M sodium phosphate buffer, pH 
7.2  (PBS 1) containing 0.2 M D-galactose. The reaction 
mixture was split into two equal portions, and 10  tzl of 
1%  glutaraldehyde in distilled  water was added to one 
of the samples. 10 min later and at each successive  10- 
min interval, 10 p.l of 1% glutaraldehyde were added to 
both reaction mixtures. When the sample containing the 
additional  10  /zl  of glutaraldehyde  displayed  a  slight 
turbidity under strong beam of visible light, the reactions 
in both samples were terminated by addition of 0.25 vol 
of 1 M glycine in PBS  1. The samples were centrifuged 
at 27,000 g for 15 min at 4~  and the small pellets were 
discarded. The supernates were pooled and centrifuged 
at  160,000  g  for  120  min  onto  a  0.5-ml  cushion  of 
Sepharose 4B  beads. After removal of the supernates 
containing unconjugated 125I-RCAII, the pellet of ferritin 
and ferritin-~SI-RCAa  was gently resuspended in PBS 1 
and purified by affinity chromatography on a 3 x  90 cm 
column of Sepharose 4B  (Pharmacia Inc., Piscataway, 
N.  J.)  or  Bio-Rad  A  1.5  m  (Bio-rad  Laboratories, 
Richmond, Calif.) as previously described (29). 
Ferritin-conjugated concanavalin A  (Ferritin-Con A) 
was synthesized using the same procedures, except that 
the conjugation buffer was 1 M sodium chloride-0.05 M 
sodium phosphate buffer, pH 6.8  (PBS 2), containing 
0.2  M  ot-methyl-D-mannopyranoside,  and  the  affinity 
column was made with Sephadex G-75 beads (29). 
Labeling Procedures 
Cells were labeled with ferritin-125I-RCA, or ferritin- 
Con  A  by  the  following  procedures:  BW5147  or 
BW5147Ric  R. 3 cells were incubated for 10 rain at 22~ 
with the ferritin conjugates at the appropriate concentra- 
tion  in  PBS  1  (ferritin-lZSI-RCAu)  or  1  M  sodium 
chloride-0.05 M sodium phosphate buffer (PBS 2) (fer- 
ritin-Con A) plus  0.1%  BSA.  The cells  were washed 
twice in PBS + 0.1% BSA and either fixed in phosphate- 
buffered  1%  glutaraldehyde  for  5  min  at  22~  or 
incubated  in  DMEM  plus  5%  horse  serum  for  an 
additional 60 min at 37~  in a humidified COs incubator. 
At the end of the 60-rain incubation, the cells were fixed 
in  phosphate-buffered 1% glutaraldehyde for 5 min at 
22~  and  washed  in  0.1  M  cacodylate buffer before 
postfixation in 1% osmium tetroxide in 0.1 M cacodylate 
buffer for 1 h at 22~  The fixed cells were centrifuged 
into soft agar, and the hardened pellets were processed 
as tissue blocks (30). The agar blocks were washed and 
dehydrated in ethanol and finally propylene oxide before 
embedding in  Spurr  resin  (Electron  Microscopy  Sci- 
ences, Fort Washington, Pa.). Thin sections were cut on 
a Reichert model OMU-3 ultramicrotome C. Reichert, 
sold by American Optical Corp., Buffalo, N. Y. with a 
diamond  knife  (Rondiken,  Honolulu),  dried,  and  ob- 
served  unstained  in  a  Hitachi  model  HU-12  electron 
microscope at 75 kV. 
RESULTS 
Properties of Ferritin- lZSl-R CA n 
Before  performing  the  ultrastructural  experi- 
ments, we examined the biological activities of the 
ferritin-12sI-toxin conjugates.  In  one  experiment, 
we  monitored  the  effectiveness of  ferritin-l~SI  - 
RCA.  in  inhibiting  the  growth  of  the  murine 
lymphoma  cell  lines.  Growth  of  the  parental 
BW5147  line  is  completely  inhibited  at  RCA. 
concentrations  >0.01  b*g/ml  and  partially  in- 
hibited  at  RCAu  concentrations  >0.001  ~g/ml 
when toxin is continuously present in the cultures 
for 48-72  h.  In contrast, the Ric  a. 3  variant line 
shows only  slight  inhibition of growth at  RCAa 
concentrations  of  0.25  /.Lg/ml,  and  some  cells 
survive even at 2.5  /xg/ml RCA.  (44). When this 
experiment was performed with RCA~r  and ferri- 
tin-lZSI-RCA, in parallel, no difference in biologi- 
cal  activity  (measured  by  cell  growth)  was  oh- 
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effects  were  specific  and  could  be  blocked  by 
inclusion of 0.1  M  D-gal or lactose in the incuba- 
tion  medium.  Similar  experiments  were  per- 
formed by pulse labeling with ~zsI-RCA, or ferri- 
tin-X25I-RCA],  for  10  min  at  22~  or  60  min  at 
37~  Since RCA. binds rapidly to cells (in most 
cases  to  plateau  values  in  under  10  min  [c.f. 
references  25  and  26],  short  incubations  with 
toxin  or  ferritin-toxin  followed  by  removal  of 
excess  toxin  and  incubation  for  24-72  h  gave 
essentially the same results (Fig.  1 a  and b).  For 
the ultrastructural experiments, concentrations of 
ferritin-X~SI-RCA. (3-10  /zg/ml toxin) were  cho- 
sen  that  resulted  in  significant amounts  of  cell 
surface  bound ferritin-XZSI-RCA, in each  experi- 
ment so that the location of a reasonable number 
of toxin molecules could be easily determined on 
each thin-sectioned cell. At the lowest dose (3/~g/ 
ml),  ferritin-~2SI-RCA, inhibits protein  synthesis 










N'~  BW5147 
i)~*r-ltSl-nCA ~ml) 








FIGURE  1  RCA n  toxicity  and binding of ferritin-~Zq  - 
RCA,  to  BW5147  and  BW5147RicR.3  cells.  (a) 
BW5147 or (b) BW5147Ric  R. 3 cells were  pulsed for 
10 min at 22~  with RCAn, washed with PBS, and then 
plated in DMEM containing 10% horse  serum. At 48, 
72, and 96 h, cell numbers and viability were determined 
(see Materials  and Methods). (c) Cells were  incubated 
with ferritin-XZSI-RCA,  for 10 min at 22~  washed twice 
in PBS containing 0.1% BSA, and fixed in 1% glutaral- 
dehyde for  5  min (22~  Controls containing 0.1  M 
lactose averaged <15% of the raw data. 
rain but has no effect on protein synthesis in the 
BW5147Ric  R. 3 variant cells." However, after 48- 
96  h,  BW5147Rica.3  variant  cells  are  growth- 
inhibited at 3  p,g/ml ferritinJZSI-RCAll "(Fig.  1). 
Quantitative binding of ferritin-]ZSI-RCA[i was 
assessed  with  BW5147  or  BW5147Rica.3  cells. 
Although  the  amounts  of  ferritin-X25I-RCA, 
bound per  cell were  RCAxz  dose-dependent  and 
usually slightly below the  levels of unconjugated 
toxin, little difference was found in specific bind- 
ing  of  ferritin-125I-RCA,i between  the  sensitive 
parental  BW5147  cells  and  the  Rica.3  variant, 
and sometimes the  resistant  Ric  a. 3  variant cells 
bound slightly more ferritin-~ZSI-RCA, (Fig.  lc). 
Ferritin-X25I-RCAit labeling could  be  blocked  by 
0.1  M  o-gal or lactose  in the  labeling and wash 
solutions as  found  previously  (19,  27).  In other 
experiments  the  ability  of  ferritin-X2SI-RCA,  to 
inhibit cell protein synthesis was monitored at 60 
and 120 min after toxin binding to BW5147 cells. 
Ferritin-X25I-RCA, (3  /xg/ml RCA.)  almost com- 
pletely  inhibited  cell  protein  synthesis  (>90%) 
within 60  min in BW5147  cells,  confirming our 
previous  results  with  fibroblastic  cells  (19,  26), 
and  there  was  little  difference  between  ferritin- 
conjugated and unconjugated toxin. 
Labeling and Dynamics of 
Fe  rritin- x25I-  R CA n 
The binding and dynamics of ferritin-~25I-RCA. 
on  RCA.-sensitive  BW5147  and  -resistant 
BW5147Ric  R. 3 cells were determined by gamma 
isotope  counting and  electron  microscopy.  Cells 
were pulsed with ferritin-125I-RCA, for 10 min at 
22~  washed, fixed with glutaraldehyde, and the 
radioactivity in each sample was determined (Fig. 
lc).  Then,  these  same  samples  were  postfixed, 
dehydrated,  and  embedded  for  electron  micros- 
copy.  When  BW5147  and  BW5147RicR'3  cells 
were labeled with ferritin-~ZSI-RCA, containing 3 
/zg/ml RCA. for 10 min, -106 ferritin-toxin mol- 
ecules bound specifically to either cell type. Ultra- 
structurally, the ferritin-X25I-RCAn  molecules were 
found at the cell surface in a more or less dispersed 
distribution (Fig. 2). Inclusion of 0.1 M lactose in 
the incubation and wash medium prevented bind- 
ing of ferritin-~25I-RCA. (Fig. 3).  When parental 
BW5147  cells  were  pulsed  for  10  min  at  22~ 
with  ferritin-~25I-RCA,  containing  1-3  /~g/ml 
z Nicolson,  G. L., and G. Poste.  1978.  Mechanism  of 
toxin resistance  in selected lymphoma variant cell lines. 
J. Supramol. Struct. In press. 
THE JOURNAL OF  CELL BIOLOGY ￿9 VOLUME 78, 1978 FIGURE  2  BW5147  cells were  labeled  with  ferritin-12SI-RCAn  (3  /zg/ml  RCAn)  for  10  min  at  22~ 
washed twice in PBS +  0.1% BSA, and fixed for electron microscopy. Bar, 0.2/zm.  ￿  63,000. 
FIGURE  3  Same as in Fig. 2, except that the samples contained 0.1  M  lactose in the labeling and wash 
solutions. Bar, 0.2/zm.  ￿  63,000. 
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at  37~  before  fixation,  many  of  the  ferritin- 
conjugated toxin molecules did not remain at the 
cell periphery, and endocytosis of the ligand was 
observed (Fig. 4). Not all of the ferritin-125I-RCAn 
molecules were endocytosed after the 60-min in- 
cubation, and the remaining surface-bound mole- 
cules  appeared  to  be  present  in  clusters  and 
patches on the cell surface. At these dose levels of 
RCAn, the variant BW5147Ric  R. 3 cells are more 
resistant to RCA~ toxic effects, and therefore the 
experiment was repeated with the resistant cells. 
Although differences in ferritin-~25I-RCAn binding 
and location on parental and Ric  R. 3 variant cells 
were not discernible immediately after the 10-min 
labeling incubation, by 60  min  after the ferritin- 
12SI-RCAn  pulse  (1-3  /~g/ml  RCAn)  there  was 
little evidence of toxin transport via endocytosis in 
the  BW5147Rica.3  cells  (Fig.  5).  However,  at 
higher  toxin  concentrations  where  the  parental 
and  Ric  a. 3  variant cells are equally sensitive to 
the  cytotoxic  effects  of  RCAH  (7-10  p.g/ml 
RCAn),  toxin-mediated endocytosis occurred  in 
both cell types (Figs. 6 and 7 at 7/zg/ml RCA~). 
Dynamics of Ferritin-Con A 
The  apparent  defect in the Ric  a. 3  cells which 
prevents  extensive  endocytosis  of  ferritinJ25I- 
RCAH at concentrations where the ferritin-conju- 
gated toxin  enters  parental BW5147  cells could 
have  been  due  to  a  general  depression  in  the 
ability to transport low concentrations of surface- 
bound  polyvalent ligands.  Therefore,  we  exam- 
ined BW5147 and the Ric  a. 3 variant line for their 
abilities to  bind  and  endocytose another  ligand, 
ferritin-Con  A.  Cells  were  pulsed  with  several 
concentrations  of  ferritin-Con  A  for  10  min, 
washed, and incubated for an additional 60 min at 
37~  as in the ferritin-~25I-RCAH  experiments. At 
low concentrations of ferritin-Con A  (3-10 p.g/ml 
Con  A), both  BW5147  and  Rica.3  cells bound 
similar amounts of ferritin-Con A  or 125I-Con A 
(Table I) and transported the ligand into cells via 
endocytosis (Figs. 8  and  9).  Although there  ap- 
peared to be a slight enhancement in ferritin-Con 
A  transport  in  the  parental  BW5147  cells,  the 
variant BW5147Ric  a. 3 cells were fully capable of 
endocytosis of this ligand. 
DISCUSSION 
Quantitative  ultrastructural  analyses of cell sur- 
face receptor distribution and dynamics are diffi- 
cult to determine and are affected by a variety of 
variables. These include the specific activity and 
valence  of  the  probe,  its  size,  charge,  binding 
strength, and other parameters (see references 3 
and 23). In some studies the substitution of ferri- 
tin-lectin reagents for native lectins did not result 
in a quantitatively similar degree of labeling (4) or 
ultrastructural distribution of lectin-binding sites 
(3). These problems were probably attributable to 
the  purity of the  starting materials, methods  of 
probe synthesis, and subsequent purification, the 
large  size  of  the  ferritin  molecule  (-150  ,~, 
hydrated)  and  the  potential  problem  that  some 
saccharide-binding sites  may  be  blocked  during 
conjugation.  We  have  used  highly  purified  re- 
agents  and  very  careful  conjugation  conditions 
which  have  been  continually  modified over  the 
years  to  synthesize  a  ferritin-125I-RCAn  probe. 
The probe was then  purified by affinity chroma- 
tography to yield a potent biologically active label. 
Comparison  of  the  ferritin-125I-RCAn  probe  to 
RCAn in  a  variety of experiments indicated that 
the ferritin-toxin conjugate was unchanged in cell 
binding and inhibition of cell growth and protein 
synthesis, important biological activities of RCAn 
(for reviews see references 20 and 37). 
RCA~ Exerts its toxic effects by a  sequence of 
events  that  results  in  inhibition  of cell  protein 
synthesis. First, the toxin binds rapidly to the cell 
surfaces of susceptible cells (almost all cells are 
susceptible  [37]) through  D-gal or D-galNAc-ter- 
minal membrane oligosaccharide residues (26, 38, 
39).  This  binding  is  very  specific  and  can  be 
blocked or reversed by D-gal or lactose (5, 19, 26, 
27, 38-40). Some cells fail to bind RCAH or ricin, 
and these are resistant to toxin-mediated cytotox- 
icity (7,  16,  17).  RCAH contains  two  separable 
polypeptides (25, 42): One of these is thought to 
be  involved in  cell binding  (35,  36),  while  the 
other is thought to inactivate cell protein synthe- 
sis. Only intact toxin molecules are  cytotoxic in 
animals and unbroken cells. 
RCAII must enter cells to act on protein synthe- 
sis, and its entry mechanism has been the subject 
of several studies. The  first clue to  the  entry of 
RCAu or ricin into cells came from kinetic studies 
on inhibition of protein synthesis. Although toxin 
molecules bind rapidly to  cells, a  lag time of at 
least 30-60 min occurs before onset of inhibition 
of  protein  synthesis  (27,  42).  This  lag  period 
corresponds  nicely  with  the  time  required  for 
aggregation of surface toxin-receptor complexes, 
endocytosis, and escape of some toxin molecules 
from endocytotic vesicles into the cytoplasm (19, 
570  THE  JOURNAL OF  CELL BIOLOGY" VOLUME 78, 1978 FIGURE  4  BW5147  cells were  labeled  with  ferritin-l~SI-RCAn  (3  p,g/ml RCA~)  for  10  min at  22~ 
washed, and  incubated  for  60  min at  37~  before  fixation.  Extensive endocytosis of the  ferritin-toxin 
occurred. Bar, 0.2 p,m.  x  63,000. 
FIGURE  5  Same  as in  Fig.  4,  except  that  BW5147Rica.3  variant  cells were  labeled  with ferritin-125I - 
RCA. (3/zg/ml RCA,). Bar, 0.2/,Lm.  ￿  63,000. FIOURE  6  Same as in  Fig. 4,  except that BW5147 cells were labeled with ferritin-12SI-RCA[~  (7  /.Lg/ml 
RCAII). Bar, 0.2/zm.  ￿  63,000. 
FIGURE  7  Same as in  Fig.  4  except  that  BW5147Ric  a-3  cells were  labeled  with  ferritin-125I-RCA[i (7 
/~g/ml RCA]0. Bar, 0.2 ta.m.  ￿  63,000. 
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Cell Line  ~zsI-Con A  clam Bound* 
BW5147 
BW5147Ric  a. 3 
#g/m/ 
1.0  3,300 -- 250 
3.0  7,800 -- 400 
10  20,100 +- 900 
10 +  a-methyl-  1,100  -+ 400 
o-mannoside 
1.0  3,800 -- 300 
3.0  8,300 --- 500 
10  22,100 _+ 1,100 
10 +  a-methyl-  1,600  -+ 400 
D-mannoside 
* 4 ￿  l0  s cells were labeled with r~sI-Con  A in PBS + 
0.1%  BSA for 10 min at 22~  and washed twice with 
PBS + 0.1% BSA. 
27).  The  30-  to  60-min lag time can be almost 
completely eliminated by using lipid vesicles with 
encapsulated toxin capable of directly introducing 
RCAB into the cytoplasm after fusion of the lipid 
vesicle  membrane  with  the  cell  plasma  mem- 
brane.2 Experiments using reticulocytes that have 
diminished endocytotic activities also indicate that 
toxin  entry  occurs  most  likely  via  endocytosis. 
Refsnes et  al.  (42)  found that  ricin bound very 
rapidly to reticulocytes, but protein synthesis was 
not  inhibited for  at  least  4  h  under conditions 
where it rapidly stopped protein synthesis in Ehr- 
lich ascites and HeLa cells. 
Once  the  toxin  molecules  have  gained  entry 
into susceptible ceils, ribosome-dependent protein 
synthesis  is  catalytically  and  irreversibly inacti- 
vated (18, 32-34). Inhibition of cell-free protein 
synthesis was  effective  when  ribosomes but  not 
supernates of cell-free systems were treated with 
toxin  (31),  and  Sperti  et  al.  (45)  found  that 
separate  in vitro treatment of the  40S  and 60S 
ribosome subunits with toxin resulted in identifi- 
cation of the 60S ribosome subunit as the site of 
toxin action. In addition, isolation and separation 
of ribosome subunits from toxin-treated cells re- 
vealed  that  the  60S,  but  not  the  40S,  subunits 
were inactivated (40). 
Toxin-resistant tumor cell variants have proven 
useful in studying the  various events leading to 
toxin-mediated cellular death  (see  Introduction). 
Since  there  are  several  possible  mechanisms 
whereby tumor cells can escape  RCAn cytotoxic 
effects, this could explain why toxin therapy has 
not  proven  universally effective  (see  review  by 
Olsnes and Pihl  [37]).  In the  present study,  an 
RCAII toxin-sensitive murine lymphoma cell line 
and its toxin-resistant variant line were compared 
for RCAII binding, transport, and cytotoxicity at 
low toxin concentrations where only the parental 
line is sensitive, and at higher toxin concentrations 
where both parental and resistant variant lines are 
susceptible  to  RCAn  killing.  Although  similar 
amounts of ferritin-125I-RCAu  are  bound to  the 
parental  and  RicR.3  variant  cells  at  low  toxin 
concentrations, the  ferritin-toxin  molecules  are 
only transported at significant levels into the sen- 
sitive  parental cells.  At  higher  toxin concentra- 
tions where  both  parental and  Ric  R.3  cells  are 
sensitive, ferritin-125I-RCAix molecules are bound 
and transported into both cell lines. The lack of 
endocytotic  transport  of  ferritin-125I-RCAH  in 
toxin-resistant Ric  a- 3 cells at low RCAxI concen- 
trations is not simply a generalized defect in cellular 
endocytosis,  because  these  cells  are  capable  of 
transporting low concentrations  of ferritin-Con A. 
The cell surface components of BW5147  and 
BW5147Ric  R. 3 cells have recently been analyzed 
using surface labeling techniques and affinity chro- 
matography (44). Of the many cell surface com- 
ponents identifiable by these techniques, two sur- 
face-exposed proteins of ~80,000 and 35,000 mol 
wt are iodinatable by lactoperoxidase techniques 
on the parental but not on the Ric  R. 3 cells. The 
larger of these  proteins is a glycoprotein-binding 
site for RCAn, while the smaller 35,000 mol wt 
component could not be  identified as  a  binding 
site for RCA~ in affinity chromatography experi- 
ments. Ric  R. 3 cells that do not possess the 80,000 
mol wt component have instead a component of 
lower molecular weight (-70,000) which can be 
isolated by affinity chromatography or precipita- 
tion  by  anti-BW5147 in  NP-40  cell  membrane 
extracts (44). 
A hypothesis for RCAn resistance in this system 
has  been  proposed  by  Robbins et  al.  (44)  that 
depends  on  the  endocytotic  transport  of  toxin 
molecules into sensitive cells mediated by the 80K 
component.  This  hypothesis  presumes  that  the 
toxin molecules bind to a  variety of cell surface 
binding sites, but that only the  80K components 
are productive receptors, and that their 70K form 
is not capable of mediating endocytotic transport 
of the toxin at low toxin concentrations. Presumed 
genetic mutation(s) in the Ric  B. 3 variant cell line 
responsible  for  the  above-described  alteration 
could be in the genes coding for the 80K compo- 
nent, glycosyltransferases that  specifically glyco- 
sylate this component, or in genes that code for or 
control a degradative enzyme that alters the 80K 
NICOLSON ET  AL.  Toxin and Lectin Receptors on Lymphoma Cell Line  573 Fmul~  8  BW5147  cells  were  labeled  with  ferritin-Con  A  (10  v,g/ml Con  A)  for  10  min  at  22~ 
washed, and incubated for 60 min at 37~  before fixation. Bar, 0.2 ~m.  x  63,000. 
FmURE  9  Same as in Fig. 8, except that BW5147Ric a. 3 variant cells  were labeled with ferritin-Con A 
(10/zg/ml Con A). Bar, 0.2/~m.  x  63,000. 
5'74  THE  JOURNAL OF  CELL BIOLOGY ￿9 VOLUME 78,  1978 component  before  insertion  into  the  cell  mem- 
brane.  The  data in this paper are consistent with 
this hypothesis but provide no direct evidence on 
the role of the 80K component in endocytosis of 
ricin. The experiments presented here suggest that 
either these or other changes in the variant could 
disrupt  the  normal  transmembrane  communica- 
tion  (21,  22) that is required to initiate a  specific 
endocytotic process resulting in toxin sensitivity. 
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